Israel - English - Ministry of Health

merck sharp & dohme israel ltd - bezlotoxumab - concentrate for solution for infusion - bezlotoxumab 25 mg / 1 ml - bezlotoxumab - zinplava is indicated for the prevention of recurrence of clostridium difficile infection (cdi) in adults who are receiving antibacterial drug treatment of cdi and are at high risk for recurrence of cdi

European Union - English - EMA (European Medicines Agency)

merck sharp & dohme b.v. - bezlotoxumab - enterocolitis, pseudomembranous - immune sera and immunoglobulins, - zinplava is indicated for the prevention of recurrence of clostridium difficile infection (cdi) in adults at high risk for recurrence of cdi.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

merck sharp & dohme ltd - bezlotoxumab - solution for infusion - 25mg/1ml

Australia - English - Department of Health (Therapeutic Goods Administration)

merck sharp & dohme (australia) pty ltd - bezlotoxumab -